Results per Page:
AMP-ed on HIV prevention
From the McElrath Lab, Vaccine and Infectious Disease Division
Natural born killers: harnessing innate immunity to fight severe infections
From the Joshua Hill lab, Vaccine and Infectious Disease Division
Driver’s ed: watching HSV co-infection and recombination in vivo
From the Jerome Lab, Vaccine & Infectious Disease Division
Anti-(idio)typical: a new immunogen to vaccinate against RSV
From the McGuire Lab, Vaccine & Infectious Disease Division
Getting a paw up in the cat-and-mouse game with the COVID-19 virus
Fred Hutch researchers invent method to quickly and safely test thousands of mutations to predict which ones could help the virus escape our defenses
Herpes cure with gene editing makes progress in laboratory studies
Fred Hutch virologists eliminated at least 90% of HSV-1 in preclinical models of oral and genital herpes and reduced viral shedding in a study published in Nature Communications
A tale of two T cells in Merkel Cell Carcinoma
From the Newell Lab, Vaccines and Infectious Disease Division
A promising HIV vaccine candidate gets a little help
New strategy stirs a robust response from T cells tracked by McElrath lab
Early research may show new way to block dengue and Zika virus
Scientists find different flavor of broadly neutralizing antibody that could lead to new vaccines for growing threat